Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
235,704,040
-
Total 13F shares
-
218,118,383
-
Share change
-
+7,509,495
-
Total reported value
-
$3,198,432,093
-
Put/Call ratio
-
62%
-
Price per share
-
$14.66
-
Number of holders
-
360
-
Value change
-
+$72,429,878
-
Number of buys
-
158
-
Number of sells
-
225
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q3 2025
As of 30 Sep 2025,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
360 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
218,118,383 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., Sachem Head Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, DIMENSIONAL FUND ADVISORS LP, and AMERICAN CENTURY COMPANIES INC.
This page lists
360
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.